In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Kesint Drug Master File in Korea (Kesint KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Kesint. The MFDS reviews the Kesint KDMF as part of the drug registration process and uses the information provided in the Kesint KDMF to evaluate the safety and efficacy of the drug.
After submitting a Kesint KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Kesint API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Kesint suppliers with KDMF on PharmaCompass.